Cargando…
Whole‐brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non‐small cell lung cancer: A single‐institution study
BACKGROUND: To compare the survival outcomes and neurocognitive dysfunction in non‐small cell lung cancer (NSCLC) patients with brain metastases (BM ≤10) treated by whole‐brain radiotherapy (WBRT) with sequential integrated boost (SEB) or simultaneous integrated boost (SIB). MATERIALS: Fifty‐two NSC...
Autores principales: | Qing, Dong, Zhao, Bin, Zhou, Yi‐Chen, Zhu, Hong‐Lei, Ma, Dai‐Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943150/ https://www.ncbi.nlm.nih.gov/pubmed/31749325 http://dx.doi.org/10.1002/cam4.2696 |
Ejemplares similares
-
The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023) -
Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018) -
Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer
por: Zhou, Lin, et al.
Publicado: (2014) -
Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases
por: Xu, Yuan, et al.
Publicado: (2022) -
Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions
por: Wang, Xiaoliang, et al.
Publicado: (2023)